Relevant Bio is developing a portfolio of native human high affinity antibodies against tumor associated antigens. Our unique ability to interrogate and detect production memory B cell has led to a robust pipeline of novel antibody-based cancer fighting therapies, all of which were discovered from humans, not mice.